If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,934.00    -78.00 (-2.59%)
Bid:
2,932.00
Ask:
2,936.00
Spread: 4.00 (0.136%)
Market Cap: £1.62b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Trading Update

18 Mar 2020 07:00

RNS Number : 5358G
Oxford Instruments PLC
18 March 2020
 

 

Oxford Instruments plc

Trading Update 18 March 2020

 

Oxford Instruments plc, a leading provider of high technology products and services to industrial companies and scientific research communities, is today issuing a trading update.

 

Given the current uncertainty from Covid-19 and the impact on trading, Oxford Instruments plc is issuing its pre-close for the financial year 2019/20 earlier than usual.

 

The severe disruption as a result of Covid-19 has impacted our customers, with a number of product shipments and installations in the final quarter of the financial year being delayed, in addition to an enforced site closure in California. While we are seeing some re-opening of customer sites in China, the situation in Europe and North America is deteriorating. As a result, the Group currently expects adjusted operating profit for the full year of between £47m to £50m.

 

Looking ahead, we expect current events to adversely impact trading during the first half of the financial year 2020/21, but at this stage there remains considerable uncertainty. The Group has a strong balance sheet and substantial liquidity, with net cash of over £50m. We operate in robust markets with a well-positioned portfolio of products and solutions for attractive end markets. We remain committed to our strategy and would expect trading to recover in line with a reduction in disruption from Covid-19.

 

Oxford Instruments' results for the year ended 31 March 2020 will be released on 9 June 2020.

 

Note: Oxford Instruments compiled consensus analyst forecast for adjusted operating profit (year to 31 March 2020) is £53.3m. This excludes analysts that have not updated forecasts following the disposals of OI Healthcare and our share in Scienta Omicron.

 

 

 

 

Enquiries:

 

Oxford Instruments plc Tel: 01865 393200

Ian Barkshire, Chief Executive

Gavin Hill, Group Finance Director

 

MHP Communications Tel: 020 3128 8100

Rachel Hirst/Alice McLaren

 

 

 

- Ends -

Issued for and on behalf of Oxford Instruments plc

Notes to Editors  

 

About Oxford Instruments plc

 

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for 60 years, supporting its core purpose to address some of the world's most pressing challenges. 

 

The first technology business to be spun out from Oxford University, Oxford Instruments is now a global company and is listed on the FTSE250 index of the London Stock Exchange (OXIG). Its strategy focuses on being a customer-centric, market-focused Group, understanding the technical and commercial challenges faced by its customers. Key market segments include Semiconductor & Communications, Advanced Materials, Healthcare & Life Science, and Quantum Technology.

 

Their portfolio includes a range of core technologies in areas such as low temperature and high magnetic field environments; Nuclear Magnetic Resonance; X-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; and advanced growth, deposition and etching.

 

Oxford Instruments is helping enable a greener economy, increased connectivity, improved health and leaps in scientific understanding. Their advanced products and services allow the world's leading industrial companies and scientific research communities to image, analyse and manipulate materials down to the atomic and molecular level, helping to accelerate R&D, increase manufacturing productivity and make ground-breaking discoveries.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKOBKKBKBFND
Date   Source Headline
1st Dec 202510:37 amPRNTotal Voting Rights
1st Dec 20257:00 amPRNTransaction in Own Shares
28th Nov 20257:00 amPRNTransaction in Own Shares
27th Nov 20257:00 amPRNTransaction in Own Shares
26th Nov 20257:00 amPRNTransaction in Own Shares
25th Nov 20257:00 amPRNTransaction in Own Shares
24th Nov 20257:00 amPRNTransaction in Own Shares
21st Nov 20257:00 amPRNTransaction in Own Shares
20th Nov 20257:00 amPRNTransaction in Own Shares
19th Nov 20257:00 amPRNTransaction in Own Shares
18th Nov 20257:00 amPRNTransaction in Own Shares
17th Nov 20257:00 amPRNTransaction in Own Shares
12th Nov 20253:00 pmPRNHolding(s) in Company
11th Nov 20257:00 amRNSHalf-Year Results
11th Nov 20257:00 amPRNTransaction in Own Shares
10th Nov 20257:00 amPRNTransaction in Own Shares
7th Nov 20257:00 amPRNTransaction in Own Shares
6th Nov 20257:00 amPRNTransaction in Own Shares
5th Nov 20257:00 amPRNTransaction in Own Shares
4th Nov 20257:00 amPRNTransaction in Own Shares
3rd Nov 20259:29 amPRNTotal Voting Rights
3rd Nov 20257:00 amPRNTransaction in Own Shares
31st Oct 20257:00 amPRNTransaction in Own Shares
30th Oct 20257:00 amPRNTransaction in Own Shares
29th Oct 20257:00 amPRNTransaction in Own Shares
28th Oct 20257:00 amPRNTransaction in Own Shares
27th Oct 20257:00 amPRNTransaction in Own Shares
24th Oct 20257:00 amPRNTransaction in Own Shares
23rd Oct 20257:00 amPRNTransaction in Own Shares
22nd Oct 20257:00 amPRNTransaction in Own Shares
21st Oct 20257:00 amPRNTransaction in Own Shares
20th Oct 20257:00 amPRNChange of Auditor
20th Oct 20257:00 amPRNTransaction in Own Shares
17th Oct 20257:00 amPRNTransaction in Own Shares
16th Oct 20257:00 amPRNTransaction in Own Shares
15th Oct 20257:00 amPRNTransaction in Own Shares
14th Oct 20257:00 amPRNTransaction in Own Shares
13th Oct 20257:41 amRNSHalf Year Trading Update - Correction
13th Oct 20257:00 amRNSHalf Year Trading Update
13th Oct 20257:00 amPRNTransaction in Own Shares
10th Oct 20257:00 amPRNTransaction in Own Shares
9th Oct 20257:00 amPRNTransaction in Own Shares
8th Oct 20257:00 amPRNTransaction in Own Shares
7th Oct 20257:00 amPRNTransaction in Own Shares
3rd Oct 20258:00 amPRNHolding(s) in Company
2nd Oct 20257:00 amPRNTransaction in Own Shares
1st Oct 202510:09 amPRNTotal Voting Rights
1st Oct 20257:00 amPRNTransaction in Own Shares
30th Sep 20257:00 amPRNTransaction in Own Shares
29th Sep 20257:00 amPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.